Thrombotic risks of oral contraceptives

@article{Rott2012ThromboticRO,
  title={Thrombotic risks of oral contraceptives},
  author={H. Rott},
  journal={Current Opinion in Obstetrics and Gynecology},
  year={2012},
  volume={24},
  pages={235–240}
}
  • H. Rott
  • Published 2012
  • Medicine
  • Current Opinion in Obstetrics and Gynecology
  • Purpose of review To inform about the risk of venous thromboembolism (VTE) of different hormonal contraceptives in different patient groups. Recent findings Combined oral contraceptives (COCs) differ significantly regarding VTE risk depending on amount of estrogen and type of progestogen: COCs containing desogestrol, gestoden or drospirenone in combination with ethinylestradiol (so called third-generation or fourth-generation COCs) are associated with a higher VTE risk than COCs with… CONTINUE READING
    An update on new orally administered contraceptives for women
    • 4
    Contraception in Patients with Rheumatic Disease.
    • 4
    Epidemiology and Risk Assessment of Pediatric Venous Thromboembolism
    • 22
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 18 REFERENCES